Trials / Completed
CompletedNCT00185146
Efficacy and Safety of Pactimibe in Patients With Atherosclerosis
Effect of Pactimibe on the Progression of Atherosclerosis as Measured by 2-D and 3-D Carotid Ultrasound
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- Sankyo Pharma Gmbh · Industry
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The effect of pactimibe on the reduction of atherosclerosis in the carotid artery will be assessed using carotid ultrasound
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pactimibe |
Timeline
- Start date
- 2002-09-01
- Completion
- 2005-08-01
- First posted
- 2005-09-16
- Last updated
- 2007-03-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00185146. Inclusion in this directory is not an endorsement.